PCM
ASTH icon

Penn Capital Management’s Astrana Health ASTH Stock Holding History

Penn Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797K Buy
+17,177
New +$618K 0.05% 134

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Penn Capital Management's ASTH Position: Q2 2026 in Review

Penn Capital Management opened a new position in Astrana Health (ASTH) in Q2 2026: 17,177 shares worth $797K. The stake represents 0.05% of the portfolio and ranks #134 among its holdings.

209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Penn Capital Management held 17,177 shares of Astrana Health worth $797K as of Q2 2026.
  • Astrana Health was a new Penn Capital Management position in Q2 2026.
  • Astrana Health made up 0.05% of Penn Capital Management's portfolio in Q2 2026, its #134 holding.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Penn Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.